Neurosciences and Neurological Disorders – SBIR-STTR (SB)
Active
- Assistance listing
- 93.NS2
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Grant awards
- Not on record
Program facts
- Treasury account
-
- 75-9915-0-1-552
- More information
Program details come from SAM.gov Assistance Listings. Updated .
About this program
The National Institute of Neurological Disorders and Stroke (NINDS), under the National Institutes of Health, funds early-stage commercializable neuroscience research through the Neurosciences and Neurological Disorders SBIR-STTR program (CFDA 93.NS2), supporting small business innovation and technology transfer in basic and applied neuroscience.
The program funds research exploring fundamental brain and nervous system structure and function, applied research addressing neurological disease mechanisms, and technology development with commercial potential. SBIR Phase I and Phase II grants comprise the portfolio, with Phase I evaluations emphasizing technological innovation and commercial viability alongside scientific merit, and Phase II assessments centered on Phase I feasibility demonstration and pathway to commercialization. Review occurs through technical panels and the National Advisory Neurological Disorders and Stroke Council, with awards based on scientific and technical merit competition.
NINDS is the sole funding agency under this Assistance Listing. The program evaluates Phase I and Phase II proposals using distinct criteria sets. Phase I review prioritizes soundness of approach, investigator qualifications, technological novelty, commercial potential, budget appropriateness, and facility adequacy. Phase II review emphasizes demonstration of Phase I feasibility, technical merit for Phase II objectives, investigator competency, innovation or societal importance, and commercial application potential. Human and animal subject protections and environmental impact assessment are required where applicable.
The source does not include recent grant award data, recent grant opportunities, or typical award magnitudes from the portfolio block. No current solicitation with an application due date is documented in the provided material. Eligible applicants are small businesses as defined under SBIR-STTR program rules. Recipients expending $750 thousand or more in federal awards annually are subject to single or program-specific audit requirements; records must be retained for a minimum of three years, or longer if audit findings remain unresolved.
Objective and description
- Objective
(1) To support extramural research funded by the National Institute of Neurological Disorders and Stroke (NINDS) including: basic research that explores the fundamental structure and function of the brain and the nervous system; research to understan
- Description
The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease for all people.
How to apply
- Criteria for selecting proposals
The major elements in evaluating proposals include assessments of: (1) the scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) the soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) the degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific and technical merit of the proposed approach for achieving the Phase II objectives; (3) the qualifications of the proposed principal investigator, supporting staff, and consultants; (4) the technological innovation, originality, or societal importance of the proposed research; (5) the potential of the proposed research for commercial application; (6) the reasonableness of the budget requested for the work proposed; (7) the adequacy and suitability of the facilities and research environment; and 8) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment.
- Award procedure
Research Grant, Training, Fellowship and SBIR/STTR applications are reviewed initially by technical panels, composed of scientific authorities, and by the National Advisory Neurological Disorders and Stroke Council composed of 18 leaders in medical science, education, and public affairs. Approved applications will compete on a merit basis for available funds. Formal award notices are transmitted to the grantee or awardee.
- Renewals
Determined as part of the NOFO
- Appeals
Other, A principal investigator (P.I.) may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute, and subsequently, the P.I. and applicant institution may appeal to the NINDS appeals officer. A description of the NIH Peer Review Appeal procedures is available on the NIH home page http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html.
Quick answers
What is Assistance Listing 93.NS2?
Assistance Listing 93.NS2 is Neurosciences and Neurological Disorders – SBIR-STTR (SB), a federal grant program run by National Institutes of Health (Department of Health and Human Services).
What is the CFDA number for Neurosciences and Neurological Disorders – SBIR-STTR (SB)?
Its CFDA number is 93.NS2: Assistance Listing numbers were called CFDA numbers before 2018.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program